AstraZeneca tests Next-Gen bird flu shots
NCT ID NCT07128615
Summary
This study is testing two new vaccines, AZD4117 and AZD5315, designed to protect against dangerous bird flu strains (H5N1 and H7N9). It involves about 405 healthy adults to see if the vaccines are safe and if they trigger a strong immune response. This is an early-stage trial to find the right dose and gather initial data.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Long Beach, California, 90815, United States
-
Research Site
Rolling Hills Estates, California, 90274, United States
-
Research Site
Hialeah, Florida, 33012, United States
-
Research Site
Stockbridge, Georgia, 30281, United States
-
Research Site
Chicago, Illinois, 60640, United States
-
Research Site
Lenexa, Kansas, 66219, United States
-
Research Site
Kansas City, Missouri, 64114, United States
-
Research Site
Omaha, Nebraska, 68134, United States
-
Research Site
Las Vegas, Nevada, 89119, United States
-
Research Site
Cincinnati, Ohio, 45212, United States
-
Research Site
Edmond, Oklahoma, 73013, United States
-
Research Site
North Charleston, South Carolina, 29405, United States
-
Research Site
Austin, Texas, 78745, United States
-
Research Site
West Jordan, Utah, 84088, United States
Conditions
Explore the condition pages connected to this study.